Sandy Hurd is a Research Advisor in CMC and brings over 20 years of pharmaceutical experience. He is the current Head of CMC at Anji Pharma where he is responsible for process development and manufacturing of clinical trial materials. Sandy has rich technical experience in drug substance and drug product from supporting preclinical regulatory toxicology studies to late clinical stage and commercial development. Additionally, he has led several small molecule discovery programs at Pharmacia, Pfizer, and Lycera in antibiotics, inflammation, and auto-immune disease areas.
Sandy received his Ph.D. in Chemistry from the University of Illinois and was a postdoctoral fellow at Harvard University.